The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2023 | How do we define smoldering multiple myeloma?
Eileen Boyle, MD, PhD, University College London, London, UK, briefly explains the criteria used to define smoldering multiple myeloma (SMM), highlighting the SLiM CRAB criteria developed by the IMWG. Dr Boyle further comments on the importance of better understanding myeloma-defining events and correctly categorizing patients who may require treatment. This interview took place at the 9th World Congress on Controversies in Multiple Myeloma (COMy) 2023, held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
